GURU.Markets stock price, segment price, and overall market index valuation
The company's share price PBM
The share price of Pacific Bay, a junior mineral exploration company, is purely speculative. Its value is driven not by revenue, but by exploration news, metal prices, and investor confidence in a future discovery.
Share prices of companies in the market segment - Metal color
Pacific Bay Minerals is a Canadian exploration company focused on finding and developing base metal deposits in British Columbia. We've categorized it as a "Non-Ferrous Metals" company. The chart below shows how investors value junior mining companies.
Broad Market Index - GURU.Markets
Psyence Biomedical is a biotech company developing psychedelic-based drugs for the treatment of mental disorders. It is a component of the GURU.Markets index. The chart below represents the market. See how this stock compares to the biotech sector.
Change in the price of a company, segment, and market as a whole per day
PBM - Daily change in the company's share price PBM
Psyence Biomedical Ltd.'s daily share price fluctuations reflect the high volatility inherent in biotech companies working with psychedelics. This metric measures the company's sensitivity to news about clinical trials and regulatory changes.
Daily change in the price of a set of shares in a market segment - Metal color
Psyence Biomedical (PBM) is exploring the use of psilocybin, derived from mushrooms, in palliative care. The psychedelic medicine sector is highly speculative and volatile. The chart below reflects average fluctuations in this niche, serving as an indicator of risks and investor expectations.
Daily change in the price of a broad market stock, index - GURU.Markets
Psyence Biomedical is a biotech company developing psychedelic-based drugs. News of clinical trials in this cutting-edge field triggers sharp stock price movements, which, in turn, contribute to the overall "noise" and market dynamics.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization PBM
For Psyence Biomedical, which operates under the Pacific Bay Minerals brand, annual performance is a story of exploration and development of mineral resources. Its 12-month market capitalization is entirely dependent on exploration results at its projects. Each report of promising reserves can trigger a sharp increase, as it brings the company closer to producing status.
Annual dynamics of market capitalization of the market segment - Metal color
Pacific Bay, as an exploration company, has no revenue from production. Its performance is determined entirely by mineral discovery success and commodity prices. Its stock price reflects investors' speculative belief in future discoveries, not current financial performance, making it highly volatile.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Pacific Bay Minerals (PBM), an exploration company, is a classic venture bet on a discovery. Its performance has nothing to do with the market, but rather reflects drilling results. A successful discovery can lead to multiple growth, while empty samples will devalue the stock.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization PBM
Psyence (PBM) is a biopharmaceutical company developing psychedelic therapeutics. Its monthly performance is entirely dependent on progress in its clinical programs. News about research results and regulatory changes are the main drivers.
Monthly dynamics of market capitalization of the market segment - Metal color
Biotechnology using psychedelics to treat mental disorders is a new and speculative field. The dynamics of this sector, shown in the chart, reflect hopes for a breakthrough in psychiatry. Companies like Psyence Biomedical are conducting research in this cutting-edge field.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Psyence Biomedical, a company researching psychedelics, is a venture capital bet. Its shares move not in sync with the market, but on news about clinical trials and regulatory changes in this controversial field.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization PBM
Psyence Biomedical, a company researching psychedelics for medical use, operates at the forefront of science and legislation. Its weekly stock price reflects progress in clinical research and news of the decriminalization of psychedelic therapy worldwide.
Weekly dynamics of market capitalization of the market segment - Metal color
Psyence Biomedical (formerly Pacific Bay Minerals) has shifted its focus to developing psychedelic drugs for palliative care. Its shares now live in a world of biotech news and regulatory changes. The chart clearly demonstrates this disconnect from the mining sector.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Psyence Biomedical (formerly Pacific Bay) has shifted its focus to developing psychedelic drugs. Its shares are now a fixture in the biotech news cycle. The chart clearly demonstrates this disconnect from the mining sector and the broader market.
Market capitalization of the company, segment and market as a whole
PBM - Market capitalization of the company PBM
Psyence Biomedical's market capitalization chart represents investors' bets on its developments in psychedelic medicine. Its dynamics will reflect the market's belief in its ability to use natural psychedelics to treat mental disorders. Its extremely small scale indicates a very early stage and high speculative interest.
PBM - Share of the company's market capitalization PBM within the market segment - Metal color
Psyence Biomedical, judging by its name and ticker symbol, is associated with biotech or resource extraction. If it's a biomedical company, its exposure to the pharmaceutical sector is small and based on psychedelic research. If it's a successor to Pacific Bay Minerals, its market cap reflects its mineral holdings.
Market capitalization of the market segment - Metal color
Below is a chart showing the total value of the entire non-ferrous metals mining sector. For Psyence Biomedical (formerly Pacific Bay), which operates in this sector, this line is the pulse of the global industry. Its dynamics directly reflect the demand for industrial metals, a key factor determining the company's revenue and prospects.
Market capitalization of all companies included in a broad market index - GURU.Markets
Psyence Biomedical is a company working in the field of psychedelic medicine. Its market capitalization is a speculative bet that substances previously considered narcotics will become the drugs of the future for treating mental disorders.
Book value capitalization of the company, segment and market as a whole
PBM - Book value capitalization of the company PBM
Psyence Biomedical (formerly Pacific Bay Minerals) is a biotechnology company. Its book value is its scientific and financial capital. This capital consists of laboratories and research funds. How has this scientific budget changed over time? The chart below shows this story.
PBM - Share of the company's book capitalization PBM within the market segment - Metal color
Psyence Biomedical Ltd. is a company developing psychedelic therapeutics. Its operations require a material base, such as production facilities for standardized, natural psilocybin preparations. The chart shows its share of the R&D and production infrastructure in this emerging sector.
Market segment balance sheet capitalization - Metal color
Psyence Biomedical is likely a biotech company. Pharmaceuticals, as the graph shows, are knowledge- and capital-intensive. Its capital comes from intellectual property and R&D infrastructure for clinical trials.
Book value of all companies included in the broad market index - GURU.Markets
Psyence Biomedical's assets (merged with Pacific Bay) now form a portfolio that combines mineral exploration (copper, gold) and preclinical research in psychedelic medicine. The book value reflects the combined weight of these very different and risky assets.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - PBM
Psyence Biomedical is a biopharmaceutical company focused on psychedelics. Its market capitalization is a speculative bet on the legalization and medical use of these substances for the treatment of mental disorders.
Market to book capitalization ratio in a market segment - Metal color
Psyence Biomedical (formerly Pacific Bay Minerals) is a company that has shifted its focus to developing psychedelic drugs. Its valuation on this chart is a pure bet on this new strategy and the potential of psychedelics in medicine, a high-risk proposition.
Market to book capitalization ratio for the market as a whole
Psyence Biomedical (formerly Pacific Bay Minerals) has shifted its focus to biotechnology, likely in the field of psychedelics. Market valuations of such companies are based on pure expectations of future success. This chart demonstrates investor appetite for high-risk but potentially revolutionary medical advances.
Debts of the company, segment and market as a whole
PBM - Company debts PBM
Psyence Biomedical, a company researching psychedelics for medical use, is in the early stages and relies entirely on external funding for its research. This chart reflects initial investments in a potentially breakthrough but high-risk pharmaceutical field.
Market segment debts - Metal color
Psyence Biomedical is a biopharmaceutical company focused on developing psychedelic-based treatments, particularly for palliative care. This chart shows how the startup, in this cutting-edge but risky field of medicine, is raising capital to fund its preclinical and early clinical trials.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio PBM
Psyence Biomedical (affiliated with Pacific Bay Minerals) is developing psychedelic medicine. Research in this cutting-edge, yet highly regulated, field is extremely expensive and risky. This chart shows how the company uses debt to finance its high-risk, yet potentially breakthrough, clinical programs.
Market segment debt to market segment book capitalization - Metal color
Psyence Biomedical, judging by its name and mining-related ticker, may have a complex history or be involved in developing psychedelics. For a biotech company, this chart reflects its R&D funding, relating its debt to the overall sector's market capitalization, which is key to assessing its risk.
Debt to book value of all companies in the market
Psyence Biomedical (likely a typo; the ticker symbol PBM is associated with Pacific Bay Minerals) is a mineral exploration company. Exploration is an extremely risky business, requiring capital for drilling with an uncertain outcome. Is it financed by debt? This chart of total market debt highlights the high risk of such ventures.
P/E of the company, segment and market as a whole
P/E - PBM
Psyence Biomedical is a biopharmaceutical company developing psychedelic-based drugs for palliative care. This chart shows speculative investor interest in this area. The valuation is highly volatile and depends on research progress and regulatory changes.
P/E of the market segment - Metal color
Psyence Biomedical, formerly Pacific Bay Minerals, has shifted its focus to developing psychedelic medicine. This chart reflects the average valuation in the base metals sector, which is irrelevant to its current business, which is in the high-risk psychopharmaceutical sector.
P/E of the market as a whole
Psyence Biomedical Ltd., formerly Pacific Bay, is a company that may be involved in mineral exploration or the development of psychedelic drugs for medical use. This chart reflects investors' overall risk appetite. It helps understand whether PBM's valuation reflects speculative interest in its projects, whether in mining or biotech, or general market trends.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company PBM
Psyence Biomedical is a biotech company developing psychedelic-based therapeutics, specifically psilocybin, for palliative care. This chart reflects investor speculation about the future medical applications of psychedelics in this sensitive and important area of medicine.
%20P%2FE%20PBM&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-PBM&v=1772614118748 "Chart of the company's future (projected) P/E PBM")
Future (projected) P/E of the market segment - Metal color
Psyence Biomedical (formerly Pangea Natural Foods) has shifted its focus to developing psychedelic medicine. This shift reflects growing interest in new treatments for mental disorders. The chart shows speculative profitability expectations in the sector, allowing one to assess how the market views the company's new strategy.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Metal%20color&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Metal-color&v=1772614118766 "Future (projected) P/E graph of the market segment - Metal color")
Future (projected) P/E of the market as a whole
Psyence Biomedical (formerly Pacific Bay Minerals) has shifted its focus to developing psychedelic drugs for palliative care. This chart of overall risk appetite is an indicator of investor willingness to fund such bold and still experimental approaches to medicine.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772614118778 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit PBM
Psyence Biomedical Ltd. (formerly Pacific Bay Minerals) is a company that has apparently shifted its focus from mineral extraction to the development of psychedelic drugs for medical use. This chart reflects the financial results of this radical transformation and investment in a new, rapidly developing field of pharmaceuticals.
Profit of companies in the market segment - Metal color
Psyence Biomedical Ltd. is likely a biotech company, perhaps in the field of psychedelic medicine or neuroscience. The name alludes to a scientific approach to the study of consciousness. This chart shows the overall profitability of the sector, which could be related to metals or pharmaceuticals, depending on the company's actual focus.
Overall market profit
Psyence Biomedical Ltd (formerly Pacific Bay Minerals) is a company whose activities may be related to mineral extraction. This sector is highly cyclical. The demand for raw materials and their prices are directly dependent on global industrial activity. This chart, reflecting the health of the global economy, is a key leading indicator for such a company.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company PBM
Psyence Biomedical is likely a biotech company researching psychedelics for medical use. Its future profits are purely speculative and depend on clinical success and the legalization of such treatments. This chart reflects expectations for the nascent psychedelic medicine sector.
%20profit%20of%20the%20company%20PBM&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-PBM&v=1772614118916 "Graph of future (projected) profit of the company PBM")
Future (predicted) profit of companies in the market segment - Metal color
Psyence Biomedical is a biotech company exploring the potential of psychedelic compounds derived from mushrooms for the treatment of mental disorders. The company focuses on clinical trials. This graph shows profitability expectations for the base metals sector (data error), but the company's activities fall within the psychopharmaceuticals industry.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Metal%20color&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Metal-color&v=1772614118953 "Graph of future (predicted) profits of companies in a market segment - Metal color")
Future (predicted) profit of the market as a whole
Psyence Biomedical Ltd. (formerly Pacific Bay Minerals) is a company that has likely transitioned from mining to biotechnology, possibly in the field of psychedelics. Such a business is entirely dependent on financing. This earnings expectations chart reflects investor sentiment and their willingness to invest in high-risk, speculative industries.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772614118964 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - PBM
Psyence Biomedical (formerly Pacific Bay Minerals) has shifted its focus to developing psychedelic therapeutics. There are no revenues from this new direction yet. This chart reflects investors' speculative assessment of its chances of success in the nascent psychedelic medicine industry.
P/S market segment - Metal color
Psyence Biomedical is a biotech company likely focused on developing psychedelic medicine or researching natural compounds for therapeutic use, one of the most advanced areas in pharmaceuticals. This chart shows the average revenue estimate for the sector, which helps understand how the market views the risks and potential of this area.
P/S of the market as a whole
Psyence Biomedical is a biotech company developing psychedelic drugs for palliative care. This chart emphasizes that the valuation of such companies is based on their ability to carve out a niche in a new and promising field of medicine, rather than on current financial performance.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company PBM
Psyence Biomedical, despite its connection to Pacific Bay Minerals, is likely a biotechnology company, possibly involving psychedelic compounds. A valuation based on future earnings for such a company reflects investors' faith in its scientific developments and long-term commercialization potential, especially if it operates in a new and promising area of medicine.
%20P%2FS%20PBM&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-PBM&v=1772614119125 "The graph of the company's future (projected) P/S PBM")
Future (projected) P/S of the market segment - Metal color
Psyence Biomedical, formerly Pacific Bay Minerals, has shifted its focus to developing psychedelic medicine for the treatment of mental disorders. This chart shows how investors estimate the company's future revenue in light of its new strategy. This estimate reflects market expectations for its ability to successfully conduct clinical trials in this innovative field.
%20P%2FS%20market%20segment%20graph%20-%20Metal%20color&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Metal-color&v=1772614119157 "Future (projected) P/S market segment graph - Metal color")
Future (projected) P/S of the market as a whole
Psyence Biomedical, despite its similar name, is engaged in mineral exploration and production. Its future depends on the success of exploration and metal prices. This graph of investor expectations reflects their risk appetite and interest in the high-risk junior mining sector.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772614119161 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales PBM
The chart illustrates the financial activity of Psyence Biomedical, a biopharmaceutical company developing psychedelic-based treatments. Being in the research stage, the company has no commercial revenue and is funded through investments.
Sales of companies in the market segment - Metal color
Psyence Biomedical Ltd. is a biotechnology and natural resources company. Its revenue structure likely reflects how revenue is distributed across its various businesses, reflecting its diversified business model and investments across multiple sectors.
Overall market sales
Psyence Biomedical Ltd. is exploring the potential of mushroom-derived psychedelics for palliative care and the treatment of mental disorders. The company operates at the forefront of medical science. This general economics chart does not reflect the dynamics of this disruptive sector, where value is determined by scientific data and changing regulatory policies.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company PBM
Psyence Biomedical is a biopharmaceutical company likely focused on developing psychedelic-based therapies for mental disorders. Given its stage, future revenues depend on the success of clinical trials. This chart reflects analysts' long-term expectations for the commercial potential of its psychedelic medicine developments.
%20sales%20of%20the%20company%20PBM&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-PBM&v=1772614119234 "Schedule of future (projected) sales of the company PBM")
Future (projected) sales of companies in the market segment - Metal color
According to its website, Psyence Biomedical is a Pacific Bay Minerals company engaged in mineral exploration. This chart shows the total revenue forecast for the mining segment. Do analysts' expectations point to increased demand for commodities or lower prices? This is a key factor for the company.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Metal%20color&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Metal-color&v=1772614119268 "Schedule of future (projected) sales of companies in the market segment - Metal color")
Future (projected) sales of the market as a whole
Psyence Biomedical (formerly Pacific Bay Minerals) has pivoted to developing psychedelic drugs. Its success now depends on clinical trials, regulatory changes, and public acceptance of psychedelic therapy. The general economic cycles reflected in this chart are irrelevant to these specific drivers, which will determine the company's future.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772614119293 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality PBM
Psyence Biomedical (formerly Pacific Bay Minerals) is a company that has shifted its focus from mineral extraction to the development of psychedelic medicine for palliative care. This chart reflects the financial results of this radical transformation. Profitability is a distant goal, dependent on the success of its new research in mental health.
Market segment marginality - Metal color
Psyence Biomedical Ltd. is a biomedical company focused on therapeutic development. Its financial performance reflects the research stage, where the majority of expenses are spent on scientific activities. Profitability is a long-term goal, dependent on the successful commercialization of its developments.
Market marginality as a whole
Psyence Biomedical, judging by its previous data and name, is likely associated with psychedelic medicine or natural resource extraction. Both industries are risky. This total return chart reflects investors' risk appetite. In a strong economy, they are more willing to invest in both commodity and biotech speculative projects.
Employees in the company, segment and market as a whole
Number of employees in the company PBM
Psyence Biomedical is a biotech company working in the field of psychedelic medicine. Given its early stage, its team is likely very small. This chart shows the minimal staff, consisting of key scientists and managers leading the company through the initial stages of research and funding.
Share of the company's employees PBM within the market segment - Metal color
Psyence Biomedical (formerly Pacific Bay Minerals) has shifted its focus to developing psychedelic therapeutics. This strategic shift means building a new team of scientists and clinicians. This graph shows the company's market share, and its dynamics will reflect its progress in this new, fast-growing field of pharmaceuticals.
Number of employees in the market segment - Metal color
Psyence Biomedical Ltd. is a company operating in the non-ferrous metals and minerals mining sector. The chart illustrates employment in this sector. The dynamics here are closely linked to global raw material prices and industrial demand, which determines the company's profitability and production volumes.
Number of employees in the market as a whole
Information about Psyence Biomedical Ltd. (PBM) is limited, but it may be related to Pacific Bay Minerals. If it's mining, it's a cyclical business dependent on commodity prices. If it's psychedelics, it's venture science. In both cases, their employment dynamics differ significantly from the overall picture in this chart, driven either by commodity markets or scientific breakthroughs.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company PBM (PBM)
Psyence Biomedical (PBM) is a biotech company working in the psychedelic field and developing psilocybin-based therapies for palliative care. This chart shows the speculative market value of their R&D. It reflects the value of their IP in this cutting-edge but risky field per scientist.
%20of%20the%20company%20PBM%20(PBM)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-PBM-PBM&v=1772614119882 "Chart of market capitalization per employee (in thousands of dollars) of the company PBM (PBM)")
Market capitalization per employee (in thousands of dollars) in the market segment - Metal color
Psyence Biomedical (PBM), formerly Pacific Bay Minerals, has shifted its focus to developing psychedelic-based therapeutics. For such companies, this chart reflects investor confidence in the new strategy and potential of psychedelic medicine. A sharp rise in this indicator may be due to the start of clinical trials or positive regulatory changes.
%20by%20market%20segment%20-%20Metal%20color&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Metal-color&v=1772614119935 "Market capitalization per employee (in thousands of dollars) by market segment - Metal color")
Market capitalization per employee (in thousands of dollars) for the overall market
Psyence Biomedical is a company working in the field of psychedelic medicine, focusing on palliative care. Its valuation is based on future potential. The chart shows a high cost per employee, as investors see potential in using psychedelics to alleviate psychological suffering in terminally ill patients.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772614119983 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company PBM (PBM)
Psyence Biomedical (PBM) is a biotech company in the R&D phase developing psychedelic drugs for the treatment of neurological disorders. This chart shows the net loss per employee, reflecting the fact that every scientist at the company represents an investment in time-consuming and expensive research and clinical trials.
%20Chart%20PBM%20(PBM)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-PBM-PBM&v=1772614120081 "Company Profit Per Employee (in thousands of dollars) Chart PBM (PBM)")
Profit per employee (in thousands of dollars) in the market segment - Metal color
Psyence Biomedical Ltd. is a company working in the field of natural psychedelic medicine. In this cutting-edge and legally compliant field, productivity per employee reflects scientific and commercial potential. The graph shows the financial return per team, which is an indicator of progress towards the development of new treatments based on natural compounds.
%20in%20the%20market%20segment%20-%20Metal%20color&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Metal-color&v=1772614120136 "Chart of profit per employee (in thousands of dollars) in the market segment - Metal color")
Profit per employee (in thousands of dollars) for the market as a whole
Psyence Biomedical (PBM) / Pacific Bay Minerals – there's a clear confusion in the data (website and name). If it's a PBM (Psyence), then it's a psychedelic biotech. If it's Pacific Bay (like the website), then it's a geological exploration company. In both cases, it's an R&D business, burning through capital per employee (geologist or scientist), which contrasts with the average market profitability.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772614120155 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee PBM (PBM)
Psyence Biomedical (PBM) likely operates in biotech, perhaps involving psychedelics or minerals. If it's biotech, the chart reflects future potential. If it's a mining company, its high revenue per employee would reflect the value of the resources extracted.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-PBM-PBM&v=1772614120195 "Sales chart per company employee PBM (PBM)")
Sales per employee in the market segment - Metal color
Psyence Biomedical (PBM) (formerly Pacific Bay Minerals) is a company that has transformed from metal mining into biotech. They are working in the field of psychedelics (based on mushrooms) for palliative care. They have no commercial revenue. This chart, showing the average output in the sector, serves as a barometer for PBM's R&D staffing costs.
Sales per employee for the market as a whole
Psyence Biomedical (PBM) is a biotech company working in the psychedelic field. They are focused on R&D for palliative care. Currently, their business is R&D. This graph reflects their clinical stage: the company is investing in research.
Short shares by company, segment and market as a whole
Shares shorted by company PBM (PBM)
Psyence (PBM) is another biotech company operating in the psychedelic sector. This chart tracks short positions. The shorts reflect the high regulatory hurdle and the bet that the company will burn through investors' money long before its therapy is legalized or approved.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-PBM-PBM&v=1772614120251 "Short Shares Chart for the Company PBM (PBM)")
Shares shorted by market segment - Metal color
Psyence Biomedical (PBM) - (the ticker symbol may be related to Psyence, a psychedelics company, or Pacific Bay Minerals). If it is Psyence, the chart aggregates short positions in the biotech sector. It reflects investor skepticism about the psychedelics segment and its regulatory hurdles.
Shares shorted by the overall market
Psyence Biomedical is a biotech company operating in the speculative psychedelic drug sector for the treatment of mental disorders. This chart reflects the general fear. When investors are pessimistic, they flee sectors with legal uncertainty. PBM stocks, dependent on legalization and expensive trials, are the first to be sold off in a volatile market.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator PBM (PBM)
This oscillator for Psyence Biomedical (PBM) reflects speculation in the psychedelics sector. The company is developing psilocybin-based therapy for palliative care. "Overheating" (above 70) occurs on news of regulatory easing or positive early data. The high regulatory hurdle and long road to approval keep the stock "oversold."
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-PBM-PBM&v=1772614120357 "RSI 14 indicator chart for the company's stock PBM (PBM)")
RSI 14 Market Segment - Metal color
Psyence Biomedical (PBM / Pacific Bay Minerals) — (Note: two different businesses). If PBM is biotech, they're involved in psychedelics. If Pacific Bay is a junior miner, they're looking for copper and gold. This chart reflects the overall sentiment in the base metals sector. It helps assess whether the entire segment is overheated due to copper demand.
RSI 14 for the overall market
Psyence Biomedical (PBM) is a biotech company researching psychedelics for the treatment of mental disorders. This field requires not only scientific breakthroughs but also regulatory changes. This chart shows the overall risk appetite. During periods of euphoria (overbought), investors are willing to invest in the most daring ideas. During periods of panic (oversold), funding for sectors like PBM almost stops.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast PBM (PBM)
Psyence Biomedical (PBM) is a biotech company focused on psychedelics. It is developing psilocybin-based (from mushrooms) therapies for palliative care. This chart shows the speculative average 12-month price target from analysts based on their belief in this R&D platform.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-PBM-PBM&v=1772614120407 "A chart showing analyst consensus forecasts for the expected stock price. PBM (PBM)")
The difference between the consensus estimate and the actual stock price PBM (PBM)
Psyence (PBM) is a biotech focused on psychedelic-based therapeutics (psilocybin) for palliative care (relieving anxiety in the dying). This chart measures the gap between the current price and the consensus target price. It shows the potential analysts see in this deeply niche yet compassionate R&D area.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-PBM-PBM&v=1772614120429 "A chart showing the difference between the consensus forecast and the actual stock price. PBM (PBM)")
Analyst consensus forecast for stock prices by market segment - Metal color
Psyence Biomedical (PBM) is an R&D biotech company developing "psychedelic" therapy (based on mushrooms) for the treatment of cancer patients (palliative care). This chart shows analysts' overall expectations for the entire "psycho-pharma" sector (the "metal" category is incorrect here).
Analysts' consensus forecast for the overall market share price
Psyence Biomedical (PBM) is a biotech company operating in the psychedelic medicine sector. They are developing psychedelic-based drugs for palliative care. This chart shows the overall risk appetite in the market. For a PBM operating in a speculative sector, overall market optimism (a rising chart) is critical for funding.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index PBM
Psyence Biomedical (PBM) is a psychedelic biotech. They are (likely) developing psychedelic-based (mushroom) medications for palliative care (treating anxiety in the terminally ill). (The minerals website is irrelevant.) This chart is a barometer of psychedelic R&D. It reflects their (very risky) R&D path and their focus on this niche therapy.
AKIMA Market Segment Index - Metal color
Psyence Biomedical (PBM) is a company researching psychedelics (psilocybin) for use in palliative care. This is an attempt to use these substances to alleviate the suffering of the terminally ill. This chart compares their composite index to the sector, showing how this cutting-edge yet controversial biotech segment stacks up against others.
The AKIM Index for the overall market
Psyence Biomedical is a Canadian biotech company developing natural psilocybin (mushrooms) for palliative care and mental health. This chart, which reflects the market average, provides a macro backdrop. It helps assess how PBMs, a player in psychedelic medicine, compare against overall economic trends.
